These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25463277)

  • 1. Iron toxicity and its possible association with treatment of Cancer: lessons from hemoglobinopathies and rare, transfusion-dependent anemias.
    Puliyel M; Mainous AG; Berdoukas V; Coates TD
    Free Radic Biol Med; 2015 Feb; 79():343-51. PubMed ID: 25463277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?
    Coates TD; Carson S; Wood JC; Berdoukas V
    Ann N Y Acad Sci; 2016 Mar; 1368(1):95-106. PubMed ID: 27186942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia: progress in molecular mechanisms and therapies.
    Sankaran VG; Weiss MJ
    Nat Med; 2015 Mar; 21(3):221-30. PubMed ID: 25742458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload and toxicity: the hidden risk of multiple blood transfusions.
    Shander A; Cappellini MD; Goodnough LT
    Vox Sang; 2009 Oct; 97(3):185-97. PubMed ID: 19663936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of iron toxicity in thalassemia.
    Hershko C
    Ann N Y Acad Sci; 2010 Aug; 1202():1-9. PubMed ID: 20712765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
    Shah FT; Porter JB; Sadasivam N; Kaya B; Moon JC; Velangi M; Ako E; Pancham S
    Br J Haematol; 2022 Jan; 196(2):336-350. PubMed ID: 34617272
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron metabolism and iron chelation in sickle cell disease.
    Walter PB; Harmatz P; Vichinsky E
    Acta Haematol; 2009; 122(2-3):174-83. PubMed ID: 19907155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of anemia in cancer patients: transfusions.
    Schrijvers D
    Oncologist; 2011; 16 Suppl 3():12-8. PubMed ID: 21930830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age.
    Berdoukas V; Nord A; Carson S; Puliyel M; Hofstra T; Wood J; Coates TD
    Am J Hematol; 2013 Nov; 88(11):E283-5. PubMed ID: 23861216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New updating into hemoglobinopathies.
    Fucharoen S; Winichagoon P
    Int J Lab Hematol; 2012 Dec; 34(6):559-65. PubMed ID: 22762348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron chelation therapy in sickle-cell disease and other transfusion-dependent anemias.
    Kwiatkowski JL; Cohen AR
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1355-77, ix. PubMed ID: 15511620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of transfusion-related iron overload in patients with myelodysplastic syndromes.
    Shah J; Kurtin SE; Arnold L; Lindroos-Kolqvist P; Tinsley S
    Clin J Oncol Nurs; 2012 Jun; 16 Suppl():37-46. PubMed ID: 22641283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions.
    Kontoghiorghes GJ
    Hemoglobin; 2006; 30(2):183-200. PubMed ID: 16798643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
    Fragasso A; Ciancio A; Mannarella C; Gaudiano C; Scarciolla O; Ottonello C; Francone M; Nardella M; Peluso A; Melpignano A; Veglio MR; Quarta G; Turchetti C
    Eur J Intern Med; 2011 Feb; 22(1):62-5. PubMed ID: 21238896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anaesthetic management of a child with hemoglobinopathy].
    Rhondali O; Pouyau A; Bonnard C; Chassard D
    Ann Fr Anesth Reanim; 2013 Dec; 32(12):e193-7. PubMed ID: 24246659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cancer-related anemia on clinical and quality-of-life outcomes.
    Gillespie TW
    Clin J Oncol Nurs; 2002; 6(4):206-11. PubMed ID: 12087616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron loading and its clinical implications.
    Hershko C
    Am J Hematol; 2007 Dec; 82(12 Suppl):1147-8. PubMed ID: 17963253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion therapy in congenital hemolytic anemias.
    Sharon BI
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1053-86. PubMed ID: 7860437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].
    Montoya Romero Jde J; Castelazo Morales E; Valerio Castro E; Velázquez Cornejo G; Nava Muñoz DA; Escárcega Preciado JA; Montoya Cossío J; Pichardo Villalón GM; Maldonado Aragón A; Santana García HR; Fajardo Dueñas S; Mondragón Galindo CG; García Lee T; García A; Hernández de Morán M; Chávez Güitrón LE; Jiménez Gutiérrez C;
    Ginecol Obstet Mex; 2012 Sep; 80(9):563-80. PubMed ID: 23243836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.